Pubblicazioni

PARP inhibitor-based treatment in metastatic, castration-resistant prostate cancer (mCRPC). A systematic review and meta-analysis

2025 - BJUI COMPASS

Roberto, Michela; Di Civita, Mattia Alberto; Marinelli, Daniele; Torchia, Andrea; Cara, Nertila; Maltese, Giulia; Speranza, Iolanda; Santini, Daniele

The future direction of imaging in prostate cancer: MRI with or without contrast injection

2021 - ANDROLOGY

Pecoraro, Martina; Messina, Emanuele; Bicchetti, Marco; Carnicelli, Giorgia; Monte, Maurizio Del; Iorio, Beniamino; La Torre, Giuseppe; Catalano, Carlo; Panebianco, Valeria

Increased Plasmatic Levels of PSA-Expressing Exosomes Distinguish Prostate Cancer Patients from Benign Prostatic Hyperplasia: A Prospective Study

2019 - CANCERS

Logozzi, Mariantonia; Angelini, Daniela F; Giuliani, Alessandro; Mizzoni, Davide; Di Raimo, Rossella; Maggi, Martina; Gentilucci, Alessandro; Marzio, Vittorio; Salciccia, Stefano; Borsellino, Giovanna; Battistini, Luca; Sciarra, Alessandro; Fais, Stefano

Challenges to treat hypogonadism in prostate cancer patients: Implications for endocrinologists, urologists and radiotherapists

2015 - TRANSLATIONAL ANDROLOGY AND UROLOGY

Gravina, Giovanni L.; DI SANTE, Stefania; Limoncin, Erika; Mollaioli, Daniele; Ciocca, Giacomo; Carosa, Eleonora; SanitÃ , Patrizia; Di Cesare, Ernesto; Lenzi, Andrea; Jannini, Emmanuele A.